Characteristics at baseline | |
Age, years | 54.8 (14.7) |
Women, % | 68 |
BMI, kg/m2 | 25.5 (5.1) |
Smoking current, % | 29 |
Hypertension, % | 15 |
Diabetes mellitus, % | 4 |
Hyperlipidemia, % | 1 |
Symptom duration, months | 6.3 (3.2) |
Seropositive, % | 68 |
DAS28 | 5.16 (1.27) |
HAQ | 0.99 (0.63) |
IgM Anti-PC, U/ml | 60.9 (36.4–94.9) |
At 1 year | |
DAS28 remission, % | 36.3 |
Use of MTX the first year, % | 50 |
Use of glucocorticosteroids the first year, % | 51 |
At 2 years | |
DAS28 remission, % | 39.5 |
Use of MTX first 2 years, % | 58 |
Use of glucocorticosteroids first 2 years, % | 53 |
Use of biological first 2 years, % | 2.4 |
IgM Anti-PC, U/ml | 56.0 (32.4–84.2) |
IgM Anti-PC AUC per 2 years, U/ml | 117.3 (68.8–201.4) |